Table 5.

Different subgroups of positive head and neck cancer patients based on their diagnosis, the number of patients in the group, the total number of positive slices within the group, and median sensitivity (%) computed from the predictions of the additional test set during the 30 iteration rounds. Values higher than the overall sensitivity in the additional test set for the given model (see Table 4) are written in bold.

Diagnosis	Patients	Slices in total	Non-augmented shallow	Augmented shallow	Non-augmented deep	Augmented deep
Adenocystic carcinoma of oral cavity	3	24	70.8	70.8	70.8	50.0
Adenocarcinoma of esophagus	2	29	86.2	82.8	82.8	69.0
Chondrosarcoma of neck	1	9	0.00	0.00	0.00	0.00
Papillary carcinoma of thyroid gland	2	33	100	100	100	100
Follicular carcinoma of thyroid gland	1	12	100	100	100	91.7
Mucoepidermoid carcinoma of parotid gland	1	5	100	100	100	100
Adnexal carcinoma of skin on neck	1	7	100	100	100	64.3